Simple intrasequence difference (SID) analysis: an original method to highlight and rank sub-structural interfaces in protein folds. Application to the folds of bovine pancreatic trypsin inhibitor, phospholipase A2, chymotrypsin and carboxypeptidase A.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Protein Engineering

• Publication date

  2003-02-01

• Fields of study

  Biology, Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1093/PROENG/GZG012PMID 12676977
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What are snake toxins

  2003cited by this paper
• Do proteins learn to evolve? The Hopfield network as a basis for the understanding of protein evolution.

  2000cited by this paper
• Redesigning the Substrate Specificity of an Enzyme by Cumulative Effects of the Mutations of Non-active Site Residues*

  1999cited by this paper
• Structural and energetic determinants of the S1-site specificity in serine proteases.

  1999cited by this paper
• Catalytic role of the active site histidine of porcine pancreatic phospholipase A2 probed by the variants H48Q, H48N and H48K.

  1999cited by this paper
• Evolutionary trace analysis of the Kunitz/BPTI family of proteins: functional divergence may have been based on conformational adjustment.

  1999cited by this paper
• Estimating the number of protein folds.

  1998cited by this paper
• Foci of amino acid residue conservation in the 3D structures of the Kunitz BPTI proteinase inhibitors: how do variants from snake venom differ?

  1997cited by this paper
• A Structure-Function Study of Bovine Pancreatic Phospholipase A Using Polymerized Mixed Liposomes (*)

  1995cited by this paper
• How are close residues of protein structures distributed in primary sequence?

  1995cited by this paper
• NMR structures of phospholipase A2 reveal conformational changes during interfacial activation

  1995cited by this paper
• Structural mechanisms for domain movements in proteins.

  1994cited by this paper
• Structure and catalytic mechanism of secretory phospholipases A2.

  1994cited by this paper
• Identification of important functional environs in protein tertiary structures from the analysis of residue variation in 3-D: application to cytochromes c and carboxypeptidases A and B.

  1994cited by this paper
• Structure-Function Relationship of Phospholipase A2 From Snake Venoms

  1994cited by this paper
• Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.

  1993cited by this paper
• Are enzymes mechanical devices?

  1993cited by this paper
• Natural protein proteinase inhibitors and their interaction with proteinases.

  1992cited by this paper
• Could domain movements be involved in the mechanism of trypsin‐like serine proteases?

  1990cited by this paper
• Chapter 4 Carboxypeptidase A

  1987cited by this paper
• The refined crystal structure of dimeric phospholipase A2 at 2.5 A. Access to a shielded catalytic center.

  1986cited by this paper
• Evolution and the tertiary structure of proteins.

  1984cited by this paper
• Structure of porcine pancreatic phospholipase A2 at 2.6 A resolution and comparison with bovine phospholipase A2.

  1983cited by this paper
• The anatomy and taxonomy of protein structure.

  1981cited by this paper
• Three-dimensional Structure of Tosyl-α-chymotrypsin

  1967cited by this paper
• Three-dimensional structure of tosyl-alpha-chymotrypsin.

  1967cited by this paper

• Capecitabine inhibits epithelial-to-mesenchymal transition and proliferation of colorectal cancer cells by mediating the RANK/RANKL pathway

  2022cites this paper
• Computational investigation of small-molecule human tissue transglutaminase inhibitors

  2017cites this paper
• A General Method for Insertion of Functional Proteins within Proteins via Combinatorial Selection of Permissive Junctions.

  2015cites this paper
• Analysis of a new crystal form of procarboxypeptidase B: further insights into the catalytic mechanism.

  2010cites this paper
• The drug discovery portal: a computational platform for identifying drug leads from academia.

  2010cites this paper
• Discovery and characterization of small molecular weight metallocarboxypeptidase inhibitors

  2009cites this paper